Editor's Note
The Food and Drug Administration (FDA) on November 22 announced the approval of RxSight Inc’s (Pasadena, California) Light Adjustable Lens and Light Delivery Device.
This is the first system that allows ophthalmologists to make small adjustments to the implanted lens’ power after cataract surgery to improve visual acuity without glasses.
Ophthalmologists can make the adjustments during several postoperative in-office procedures.
The poster presentations at the 2024 OR Manager Conference showcased…
The promise of quicker recovery and fewer complications from sedation,…
New York, New York (January 31, 2024)–Sonio today announced that…